Calcium-sensing receptor autoantibody-mediated hypoparathyroidism associated with immune checkpoint inhibitor therapy : diagnosis and long-term follow-up

Dadu, R., Rodgers, T.E., Trinh, V.A. et al. (6 more authors) (2020) Calcium-sensing receptor autoantibody-mediated hypoparathyroidism associated with immune checkpoint inhibitor therapy : diagnosis and long-term follow-up. Journal for ImmunoTherapy of Cancer, 8 (1). e000687. ISSN 2051-1426

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © Author(s) (or their employer(s)) 2020. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.
Keywords: Autoantibody; Autoimmunity; Calcium-sensing receptor; Hypoparathyroidism; Immune checkpoint inhibitor; Ipilimumab; Nivolumab
Dates:
  • Accepted: 7 May 2020
  • Published (online): 24 June 2020
  • Published: 24 June 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 13 May 2020 07:22
Last Modified: 10 Jul 2020 12:21
Status: Published
Publisher: BMJ Publishing Group
Refereed: Yes
Identification Number: https://doi.org/10.1136/jitc-2020-000687

Download

Share / Export

Statistics